Intended for healthcare professionals

Latest dermatology news

 

BioNTech’s mRNA immunotherapy candidate shows promise in advanced melanoma

BNT111 in combination with Libtayo previously received fast track designation from the US Food and Drug Administration

06 Sep 2024

FDA approves Galderma’s monoclonal antibody Nemluvio to treat prurigo nodularis

The regulator is also reviewing the IL-31 inhibitor as a treatment for atopic dermatitis

29 Aug 2024

Almirall receives NICE recommendation for Ebglyss in moderate-to-severe atopic dermatitis

The IL-13 inhibitor can now be used to treat adults and adolescents who are candidates for systemic therapy

22 Aug 2024

Boehringer receives positive CHMP opinion for Spevigo in generalised pustular psoriasis

The inflammatory disease can lead to complications including multisystem organ failure and sepsis
 

08 Aug 2024

FDA approves Sun Pharma’s Leqselvi to treat severe alopecia areata in adults

The oral JAK inhibitor is designed to interrupt the pathways that are thought to contribute to hair loss

01 Aug 2024

LEO Pharma granted positive CHMP opinion for Anzupgo in chronic hand eczema

The JAK inhibitor has been recommended for patients who have had an inadequate response to, or have not been advised, topical corticosteroids
 

01 Aug 2024

Bristol Myers Squibb’s Opdualag granted SMC approval to treat advanced melanoma

Approximately 10% of all melanoma cases in the UK are diagnosed at more advanced stages

25 Jul 2024

FDA approves Arcutis’ Zoryve cream to treat atopic dermatitis in adult and paediatric patients

The PDE4 inhibitor is already approved in the US to treat seborrhoeic dermatitis and plaque psoriasis

18 Jul 2024

Almirall’s Ilumetri associated with well-being improvements in plaque psoriasis study

Almost 77% of patients have reported that the condition negatively affects their daily activities and well-being

11 Jul 2024

Almirall granted expanded FDA approval for Klisyri in actinic keratosis

The precancerous condition has an estimated prevalence of 13.3% in Europe

05 Jul 2024
12345678910...